|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
|
Test specifications |
|
|
a) Test method |
WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.3.14 (Version adopted in May 2021) |
|
b) Test type |
Qualitative |
|
c) Sample type |
Swabs: Cloacal and oropharyngeal Tissues: Brain, trachea, heart, lung, spleen, liver, intestine and kidney |
|
d) Sample Volume/Amount |
Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of tissues/organs |
|
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’ |
|
f) TAT |
7 - 14 working days |
|
g) Results |
Refer ‘CVRL- Guidelines’, section ‘’Results’’ |
|
h) Measurement of Uncertainty (MU) |
N/A |
|
i) Expression of result |
Virus isolated or no virus isolated |
|
Test: Influenza A virus (All avian Influenza strains including H5, H7 & H9) |
|
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
|
Test specifications |
|
|
a) Test method |
WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.3.4 (Version adopted in May 2021) |
|
b) Test type |
Qualitative |
|
c) Sample type |
Swabs: Cloacal and oropharyngeal Tissues: Brain, trachea, heart, lung, spleen, liver, intestine and kidney |
|
d) Sample Volume/Amount |
Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of tissues/organs |
|
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’ |
|
f) TAT |
7 - 14 working days |
|
g) Results |
Refer ‘CVRL- Guidelines’, section ‘’Results’’ |
|
h) Measurement of Uncertainty (MU) |
N/A |
|
i) Expression of result |
Virus isolated or no virus isolated |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
|
Test specifications |
|
|
a) Test method |
WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.7 (Version adopted in May 2019) |
|
b) Test type |
Qualitative |
|
c) Sample type |
Swab: Nasal Transtracheal lavage |
|
d) Sample Volume/Amount |
Swabs must be send in viral transport medium which can be collected from CVRL. Transtracheal lavage - 10 ml |
|
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ section ‘’Sending a sample’’ |
|
f) TAT |
7 - 14 working days |
|
g) Results |
Refer ‘CVRL- Guidelines’, section ‘’Results’’ |
|
h) Measurement of Uncertainty (MU) |
N/A |
|
i) Expression of result |
Virus isolated or no virus isolated |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
|
Test specifications |
|
|
a) Test method |
WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.10 (Version adopted in May 2013) |
|
b) Test type |
Serum |
|
c) Sample type |
Quantitative |
|
d) Sample Volume/Amount |
5 - 7 ml |
|
e) Sample submission |
CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’ |
|
f) TAT |
5 - 14 working days |
|
g) Results |
Refer ‘CVRL- Guidelines’, section ‘’Results’’ |
|
h) Measurement of Uncertainty (MU) |
N/A |
|
i) Expression of result |
Negative or Positive (positive serum is reported in titers) |
|
j) Cut off titers |
Negative: A titer < 1:4 is considered negative Positive: A titer of 1:4 or greater is considered positive |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
|
Test specifications |
|
|
a) Test method |
WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.8 (Version adopted in May 2021) |
|
b) Test type |
Serum |
|
c) Sample type |
Quantitative |
|
d) Sample Volume/Amount |
5 - 7 ml |
|
e) Sample submission |
CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’ |
|
f) TAT |
4 - 5 working days |
|
g) Results |
Refer ‘CVRL- Guidelines’, section ‘’Results’’ |
|
h) Measurement of Uncertainty (MU) |
N/A |
|
i) Expression of result |
Negative, Positive (positive serum is reported in titers) or dubious |
|
j) Cut off titers |
Negative: A titer <1:80 is considered negative Positive: A titer of 1:80+++ or greater is considered positive Dubious: A titer of 1:80+ or 1:80++ |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
|
Test specifications |
|
|
a) Test method |
WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.5.2 (Version adopted in May 2021) |
|
b) Test type |
Qualitative |
|
c) Sample type |
Swab: Nasal Tissues: Lung and trachea |
|
d) Sample Volume/Amount |
Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of tissues/organs |
|
e) Sample submission |
CVRL does not conduct site visit and sampling. Refer ‘CVRL- Guidelines’, section ‘’Sending a sample’’ |
|
f) TAT |
7 - 14 working days |
|
g) Results |
Refer ‘CVRL- Guidelines’, section ‘’Results’’ |
|
h) Measurement of Uncertainty (MU) |
N/A |
|
i) Expression of result |
Virus isolated or no virus isolated |